124 related articles for article (PubMed ID: 24131890)
1. Patients with prostate cancer continue to have excess mortality up to 15 years after diagnosis.
Husson O; van Steenbergen LN; Koldewijn EL; Poortmans PM; Coebergh JW; Janssen-Heijnen ML
BJU Int; 2014 Nov; 114(5):691-7. PubMed ID: 24131890
[TBL] [Abstract][Full Text] [Related]
2. Minimal excess mortality for long-term colon cancer survivors in the Netherlands 1989-2008.
van Steenbergen LN; Steur M; Lemmens VE; Rutten HJ; van Spronsen DJ; Janssen-Heijnen ML
Eur J Cancer; 2013 Feb; 49(3):585-92. PubMed ID: 22967727
[TBL] [Abstract][Full Text] [Related]
3. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of conditional survival of cancer patients in europe: age-specific analyses of 13 cancers.
Janssen-Heijnen ML; Gondos A; Bray F; Hakulinen T; Brewster DH; Brenner H; Coebergh JW
J Clin Oncol; 2010 May; 28(15):2520-8. PubMed ID: 20406936
[TBL] [Abstract][Full Text] [Related]
5. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.
Bray F; Klint A; Gislum M; Hakulinen T; Engholm G; Tryggvadóttir L; Storm HH
Acta Oncol; 2010 Jun; 49(5):644-54. PubMed ID: 20151937
[TBL] [Abstract][Full Text] [Related]
6. Long-term excess mortality for survivors of non-small cell lung cancer in the Netherlands.
Janssen-Heijnen ML; van Steenbergen LN; Steyerberg E; Visser O; De Ruysscher DK; Groen HJ
J Thorac Oncol; 2012 Mar; 7(3):496-502. PubMed ID: 22246194
[TBL] [Abstract][Full Text] [Related]
7. Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best?
van Erning FN; van Steenbergen LN; Lemmens VEPP; Rutten HJT; Martijn H; van Spronsen DJ; Janssen-Heijnen MLG
Eur J Cancer; 2014 Jul; 50(10):1731-1739. PubMed ID: 24814358
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.
Brenner H; Arndt V
J Clin Oncol; 2005 Jan; 23(3):441-7. PubMed ID: 15572727
[TBL] [Abstract][Full Text] [Related]
9. Conditional survival of malignant melanoma in The Netherlands: 1994-2008.
van der Leest RJ; van Steenbergen LN; Hollestein LM; de Vries E; Nijsten T; van Akkooi AC; Janssen-Heijnen ML; Coebergh JW
Eur J Cancer; 2014 Feb; 50(3):602-10. PubMed ID: 24262585
[TBL] [Abstract][Full Text] [Related]
10. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis.
Bouvier AM; Remontet L; Hédelin G; Launoy G; Jooste V; Grosclaude P; Belot A; Lacour B; Estève J; Bossard N; Faivre J;
Cancer; 2009 Oct; 115(19):4616-24. PubMed ID: 19569252
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer.
Bul M; van den Bergh RC; Zhu X; Rannikko A; Vasarainen H; Bangma CH; Schröder FH; Roobol MJ
BJU Int; 2012 Dec; 110(11):1672-7. PubMed ID: 22928973
[TBL] [Abstract][Full Text] [Related]
12. Prognosis for long-term survivors of cancer.
Janssen-Heijnen ML; Houterman S; Lemmens VE; Brenner H; Steyerberg EW; Coebergh JW
Ann Oncol; 2007 Aug; 18(8):1408-13. PubMed ID: 17693654
[TBL] [Abstract][Full Text] [Related]
13. Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands.
Janssen-Heijnen ML; van Steenbergen LN; Voogd AC; Tjan-Heijnen VC; Nijhuis PH; Poortmans PM; Coebergh JW; van Spronsen DJ
Ann Oncol; 2014 Jan; 25(1):64-8. PubMed ID: 24201973
[TBL] [Abstract][Full Text] [Related]
14. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
[TBL] [Abstract][Full Text] [Related]
15. Increased non-prostate cancer death risk in clinically diagnosed prostate cancer.
van Leeuwen PJ; Otto SJ; Kranse R; Roobol MJ; Bul M; Zhu X; de Koning H; Schröder FH
BJU Int; 2012 Jul; 110(2):188-94. PubMed ID: 22288823
[TBL] [Abstract][Full Text] [Related]
16. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.
Hannibal CG; Cortes R; Engholm G; Kjaer SK
Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210
[TBL] [Abstract][Full Text] [Related]
17. Prostate carcinoma and long term survival.
Adolfsson J; Rutqvist LE; Steineck G
Cancer; 1997 Aug; 80(4):748-52. PubMed ID: 9264359
[TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
[TBL] [Abstract][Full Text] [Related]
19. Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden.
Aus G; Robinson D; Rosell J; Sandblom G; Varenhorst E;
Cancer; 2005 Mar; 103(5):943-51. PubMed ID: 15651057
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival of prostate cancer in southeastern Netherlands.
Post PN; Hendrikx AJ; Hansen BE; van der Heijden LH; Coebergh JW
Acta Oncol; 2000; 39(1):101-4. PubMed ID: 10752662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
